It has been reported that during the progression of prostate cancer (PCa), aberrantly expressed HOXA2, HOXA9, and HOXA10 facilitate the infiltration of dendritic cells, macrophages, and mastocytes [80]. Here, HOXA9 is linked to prostate carcinoma.